Thursday, April 07, 2011 2:16:38 PM
By Jack Kaskey - Apr 7, 2011 10:41 AM PT
Huntsman Corp. (HUN), the world’s third- biggest producer of titanium-dioxide pigment, gained in New York trading after the company said profit margins for the white paint ingredient widened in the first quarter.
Huntsman increased prices about $400 a ton in the quarter and each $100 gain adds $50 million to earnings before interest, tax, depreciation and amortization, Chief Executive Officer J. Kimo Esplin said today in a presentation on the company’s website. Rising raw-material costs will erode some of the margin expansion, he said.
“We’re going to still expand margins and we’re going to expand them at a pretty good rate,” Esplin said. “Just don’t forget the headwinds that we are all experiencing.”
Huntsman, which is run from offices in Salt Lake City and The Woodlands, Texas, rose as much as 7 percent and was 99 cents, or 5.6 percent, higher at $19.10 as of 1:18 p.m. in New York Stock Exchange composite trading.
The largest titanium dioxide maker is DuPont Co., followed by Cristal Global, Esplin said. The chemical adds opacity and whiteness in paints, plastics and paper.
Recent HUN News
- Huntsman Announces First Quarter 2024 Earnings • PR Newswire (US) • 05/02/2024 08:14:00 PM
- Huntsman Scholarship Program Awards 19 Spring ISD Students • PR Newswire (US) • 04/25/2024 05:30:00 PM
- Huntsman To Donate $500,000 Over Next Five Years to Montgomery County Food Bank to Help Feed Additional 5,000 Households Per Month • PR Newswire (US) • 04/03/2024 03:30:00 PM
- Huntsman to Discuss First Quarter 2024 Results on May 3, 2024 • PR Newswire (US) • 04/01/2024 11:38:00 PM
- Huntsman Announces Fourth Quarter 2023 Earnings • PR Newswire (US) • 02/21/2024 09:45:00 PM
- Huntsman Announces 5% Increase in First Quarter 2024 Common Dividend and 2024 Annual Meeting of Stockholders • PR Newswire (US) • 02/21/2024 09:44:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:30:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:35:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:34:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:33:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:33:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:32:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:31:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:30:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:29:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:28:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:27:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:27:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:25:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:25:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:23:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:22:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:22:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:21:51 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:23:48 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM